# Establishment Labs Holdings Inc. (ESTA)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $2.35B  
**Price:** $79.46 (-0.45%)

> Establishment Labs Holdings Inc. is a medical technology company that manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. Its primary products include silicone gel-filled breast implants and body-shaping implants under the renowned Motiva Implants brand, featuring advanced technologies such as SilkSurface, SmoothSilk, VelvetSurface, ProgressiveGel, TrueMonobloc, BluSeal, Divina, Ergonomix, and others. The company also offers breast tissue expanders to support surgical procedures. Establishment Labs Holdings Inc. distributes its innovative implants through direct sales to physicians, hospitals, and clinics, as well as via medical distributors worldwide. Its operations span key geographical segments including Europe, Latin America, Asia-Pacific/Middle East, and other regions, serving professionals in the aesthetic and reconstructive sectors. Founded in 2004 and headquartered in Austin, Texas, Establishment Labs Holdings Inc. plays a vital role in advancing minimally invasive cosmetic procedures and body contouring solutions within the global medical devices market.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $211M | $146M | -$39M | -$51M | $-1.72 |
| 2024 | $166M | $110M | -$50M | -$85M | $-3.00 |
| 2023 | $165M | $107M | -$65M | -$79M | $-3.07 |
| 2022 | $162M | $107M | -$40M | -$75M | $-3.08 |
| 2021 | $127M | $85M | -$25M | -$41M | $-1.72 |
| 2020 | $85M | $53M | -$28M | -$38M | $-1.63 |
| 2019 | $90M | $55M | -$31M | -$38M | $-1.86 |
| 2018 | $61M | $36M | -$24M | -$21M | — |
| 2017 | $35M | $18M | -$20M | -$35M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $357M | $334M | $24M | $76M | $248M |
| 2024 | $347M | $294M | $53M | $90M | — |
| 2023 | $269M | $250M | $18M | $40M | $189M |
| 2022 | $211M | $219M | -$8M | $66M | $175M |
| 2021 | $140M | $89M | $51M | — | $52M |
| 2020 | $156M | $81M | $75M | — | $50M |
| 2019 | $117M | $77M | $40M | — | $48M |
| 2018 | $117M | $47M | $69M | $53M | — |
| 2017 | $57M | $62M | -$5M | $11M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$51M | $6M | -$57M |
| 2024 | -$59M | $6M | -$65M |
| 2023 | -$89M | $8M | -$96M |
| 2022 | -$52M | $3M | -$55M |
| 2021 | -$28M | $2M | -$30M |
| 2020 | -$13M | $2M | -$15M |
| 2019 | -$30M | $6M | -$36M |
| 2018 | -$34M | $2M | -$36M |
| 2017 | -$32M | $901,000 | -$33M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ESTA)